Delivery Order SPE2DE21D7010-SPE2D626F17C1
- Not listed
- This delivery order, valued at $11,287.94, was awarded to Nuvasive, Inc. on December 4, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain for the provision of MODULUS spinal surgical products. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of January 8, 2026. Performance will be conducted at Nuvasive's facility in San Diego, California. This award was issued without set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $11,287.94 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. The contract, designated as Delivery Order 4570101607, involves the procurement of MODULUS spinal surgical products and is structured as a fixed-price agreement with economic price adjustment provisions to accommodate cost fluctuations in specialized medical device...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $11,287.94 on January 27, 2026, by the Defense Logistics Agency Medical Supply Chain for the supply of MODULUS spinal surgical products. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 28, 2026, with performance conducted at Nuvasive's San Diego, California facility. The award was made...
- This delivery order, awarded November 6, 2025, represents a $3,227.70 fixed-price contract with economic price adjustment provisions issued by the Defense Logistics Agency Medical Supply Chain to Nuvasive, Inc. for the delivery of MODULUS spinal surgical products. The contract will be performed at Nuvasive's San Diego, California facility with an ultimate completion date of November 7, 2025, reflecting the urgent medical supply requirements of the Defense Health System. This is a non-set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $5,293.64 on January 22, 2026, for MODULUS spinal surgical products and services. This fixed-price contract with economic price adjustment is scheduled for completion by February 17, 2026, and will be performed at Nuvasive's San Diego facility. The award was issued under a competitive, open-market procurement with no set-aside designation by the...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $5,477.02 on December 4, 2025, for the MODULUS spinal surgical product through the Defense Logistics Agency (DLA) Medical Supply Chain. This fixed-price contract with economic price adjustment provisions is scheduled for completion by December 31, 2025, with performance occurring at Nuvasive's San Diego facility. The award carries no set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $7,679.70 on January 9, 2026, for the supply of MODULUS spinal surgical products. This fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by January 30, 2026, and will be performed at Nuvasive's San Diego facility. The contract was issued without set-aside designation through the Defense Logistics Agency...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $23,821.62 fixed-price delivery order (4570470032) by the Defense Logistics Agency Medical Supply Chain on January 7, 2026. This delivery order, designated as MODULUS and structured with economic price adjustment provisions, calls for performance completion by January 30, 2026, at Nuvasive's San Diego, California facility. The award was made...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $22,128.07 on November 25, 2025, for the supply of MODULUS spinal surgical products and related medical devices. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by January 2, 2026, with performance conducted at Nuvasive's San Diego, California facility. The contract was issued without set-aside...
- This delivery order, valued at $19,373.40, was awarded to Nuvasive, Inc. on July 21, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency. The contract utilizes a fixed-price structure with economic price adjustment provisions and will be performed in San Diego, California, with completion targeted for August 12, 2025. The award is associated with the MODULUS product line and was made without a set-aside designation, indicating open competition....
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F17C1Delivery Order
This delivery order, valued at $15,421.95, was awarded on November 25, 2025, to Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in advanced spinal surgery products and services for federal healthcare agencies. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare facilities. The award is not designated as a set-aside contract and will be performed at Nuvasive's San Diego, California facility, with an ultimate completion date of January 5, 2026. Nuvasive is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and competes actively in open market federal procurements without restrictions. This delivery order is likely issued against the $8 million Blanket Purchase Agreement established between Transplant Technology Inc. and the Defense Health Agency, structured as an Indefinite Delivery/Indefinite Quantity contract vehicle effective through March 2027. The BPA enables streamlined procurement and rapid ordering of Nuvasive's comprehensive portfolio of spinal fusion devices, interbody implants, bone graft materials, and specialized surgical instruments, including the MODULUS product referenced in this award. The delivery order structure and short performance timeline reflect the urgent medical supply requirements of the military health system, allowing federal healthcare providers to efficiently access specialized spinal technologies required for advanced surgical capabilities across Department of Defense and Veterans Health Administration medical facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 11/24/25 |